Novartis Europharm Limited
- A10 - Antidiabéticos
- EUCREAS film-coated tablet 1 000 mg+50 mg
- EUCREAS film-coated tablet 850 mg+50 mg
- GALVUS tablet 100 mg
- GALVUS tablet 50 mg
- ICANDRA film-coated tablet 1 000 mg+50 mg
- ICANDRA film-coated tablet 850 mg+50 mg
- JALRA tablet 50 mg
- STARLIX film-coated tablet 120 mg
- STARLIX film-coated tablet 180 mg
- STARLIX film-coated tablet 60 mg
- XILIARX tablet 50 mg
- ZOMARIST film-coated tablet 1 000 mg+50 mg
- ZOMARIST film-coated tablet 850 mg+50 mg
- B02 - Antihemorrágicos
- REVOLADE film-coated tablet 25 mg
- REVOLADE film-coated tablet 50 mg
- REVOLADE film-coated tablet 75 mg
- REVOLADE powder for oral suspension 25 mg
- B06 - Otros agentes hematológicos
- ADAKVEO concentrate for solution for infusion 100 mg/10 ml
- C09 - Agentes activos sobre el sistema renina-angiotensina
- COPALIA film-coated tablet 160 mg+10 mg
- COPALIA film-coated tablet 160 mg+5 mg
- COPALIA film-coated tablet 80 mg+5 mg
- COPALIA HCT film-coated tablet 160 mg+10 mg+12.5 mg
- COPALIA HCT film-coated tablet 160 mg+10 mg+25 mg
- COPALIA HCT film-coated tablet 160 mg+5 mg+12.5 mg
- COPALIA HCT film-coated tablet 160 mg+5 mg+25 mg
- COPALIA HCT film-coated tablet 320 mg+10 mg+25 mg
- DAFIRO film-coated tablet 160 mg+10 mg
- DAFIRO film-coated tablet 160 mg+5 mg
- DAFIRO film-coated tablet 80 mg+5 mg
- DAFIRO HCT film-coated tablet 160 mg+10 mg+12.5 mg
- DAFIRO HCT film-coated tablet 160 mg+10 mg+25 mg
- DAFIRO HCT film-coated tablet 160 mg+5 mg+12.5 mg
- DAFIRO HCT film-coated tablet 160 mg+5 mg+25 mg
- DAFIRO HCT film-coated tablet 320 mg+10 mg+25 mg
- ENTRESTO film-coated tablet 24 mg+26 mg
- ENTRESTO film-coated tablet 49 mg+51 mg
- ENTRESTO film-coated tablet 97 mg+103 mg
- EXFORGE film-coated tablet 10 mg+160 mg
- EXFORGE film-coated tablet 5 mg+160 mg
- EXFORGE film-coated tablet 5 mg+80 mg
- EXFORGE HCT film-coated tablet 10 mg+160 mg+12.5 mg
- EXFORGE HCT film-coated tablet 10 mg+160 mg+25 mg
- EXFORGE HCT film-coated tablet 10 mg+320 mg+25 mg
- EXFORGE HCT film-coated tablet 5 mg+160 mg+12.5 mg
- EXFORGE HCT film-coated tablet 5 mg+160 mg+25 mg
- NEPARVIS film-coated tablet 103 mg+97 mg
- NEPARVIS film-coated tablet 26 mg+24 mg
- NEPARVIS film-coated tablet 51 mg+49 mg
- RIPRAZO film-coated tablet 150 mg
- RIPRAZO film-coated tablet 300 mg
- L01 - Antineoplásicos
- AFINITOR tablet 10 mg
- AFINITOR tablet 2.5 mg
- AFINITOR tablet 5 mg
- ATRIANCE solution for infusion 5 mg/ml
- GLIVEC capsule, hard 100 mg
- GLIVEC capsule, hard 50 mg
- GLIVEC film-coated tablet 100 mg
- GLIVEC film-coated tablet 400 mg
- HYCAMTIN NOVARTIS powder for solution for infusion 1 mg/1 ml
- JAKAVI tablet 10 mg
- JAKAVI tablet 15 mg
- JAKAVI tablet 20 mg
- JAKAVI tablet 5 mg
- KISQALI film-coated tablet 200 mg
- KYMRIAH dispersion 1 200 000 - 600 000 000 cells
- MEKINIST film-coated tablet 0.5 mg
- MEKINIST film-coated tablet 1 mg
- MEKINIST film-coated tablet 2 mg
- PIQRAY film-coated tablet 150 mg
- PIQRAY film-coated tablet 200 mg
- PIQRAY film-coated tablet 50 mg - 200 mg
- RYDAPT capsule, soft 25 mg
- SCEMBLIX film-coated tablet 20 mg
- SCEMBLIX film-coated tablet 40 mg
- TAFINLAR capsule, hard 50 mg
- TAFINLAR capsule, hard 75 mg
- TASIGNA capsule, hard 150 mg
- TASIGNA capsule, hard 200 mg
- TASIGNA capsule, hard 50 mg
- TYVERB film-coated tablet 250 mg
- VOTRIENT film-coated tablet 200 mg
- VOTRIENT film-coated tablet 400 mg
- VOTUBIA dispersible tablet 1 mg
- VOTUBIA dispersible tablet 2 mg
- VOTUBIA dispersible tablet 3 mg
- VOTUBIA dispersible tablet 5 mg
- VOTUBIA tablet 10 mg
- VOTUBIA tablet 2.5 mg
- VOTUBIA tablet 5 mg
- ZYKADIA capsule, hard 150 mg
- ZYKADIA film-coated tablet 150 mg
- L03 - Inmunoestimulantes
- EXTAVIA powder and solvent for solution for injection 250 µg+1 ml
- L04 - Inmunosupresores
- COSENTYX PREFILLED SYRINGE solution for injection 150 mg/1 ml
- COSENTYX PREFILLED SYRINGE solution for injection 300 mg/1 ml
- COSENTYX PREFILLED SYRINGE solution for injection 75 mg/1 ml
- GILENYA capsule, hard 0.25 mg
- GILENYA capsule, hard 0.5 mg
- ILARIS powder and solvent for solution for injection 150 mg
- ILARIS powder for solution for injection 150 mg
- ILARIS solution for injection 150 mg/ml
- KESIMPTA PRE-FILLED PEN solution for injection 20 mg/0.4 ml
- KESIMPTA PRE-FILLED SYRINGE solution for injection 20 mg/0.4 ml
- MAYZENT film-coated tablet 0.25 mg
- SIMULECT powder and solvent for solution for injection 10 mg+2.5 ml
- M05 - Preparados para el tratamiento de enfermedades óseas
- ACLASTA solution for infusion 5 mg/100 ml
- M09 - Otros medicamentos para desórdenes del sistema musculoesquelético
- ZOLGENSMA solution for infusion
- N02 - Analgésicos
- AIMOVIG solution for injection 70 mg/ml
- N06 - Psicoanalépticos
- EXELON capsule, hard 1.5 mg
- EXELON capsule, hard 3 mg
- EXELON capsule, hard 4.5 mg
- EXELON capsule, hard 6 mg
- EXELON oral solution 2 mg/ml
- EXELON transdermal patch 13.3 mg/24 h
- EXELON transdermal patch 4.6 mg/24 h
- EXELON transdermal patch 9.5 mg/24 h
- PROMETAX capsule, hard 1.5 mg
- PROMETAX capsule, hard 3 mg
- PROMETAX capsule, hard 4.5 mg
- PROMETAX capsule, hard 6 mg
- PROMETAX oral solution 2 mg/ml
- PROMETAX transdermal patch 13.3 mg/24 h
- PROMETAX transdermal patch 4.6 mg/24 h
- PROMETAX transdermal patch 9.5 mg/24 h
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- ATECTURA BREEZHALER inhalation powder, hard capsule 125 µg+127.5 µg
- ATECTURA BREEZHALER inhalation powder, hard capsule 125 µg+260 µg
- ATECTURA BREEZHALER inhalation powder, hard capsule 125 µg+62.5 µg
- BEMRIST BREEZHALER inhalation powder, hard capsule 125 µg+127.5 µg
- BEMRIST BREEZHALER inhalation powder, hard capsule 125 µg+260 µg
- BEMRIST BREEZHALER inhalation powder, hard capsule 125 µg+62.5 µg
- ENERZAIR BREEZHALER inhalation powder, hard capsule 114 µg+46 µg+136 µg
- ENUREV BREEZHALER inhalation powder, hard capsule 44 µg
- HIROBRIZ BREEZHALER inhalation powder, hard capsule 150 µg
- HIROBRIZ BREEZHALER inhalation powder, hard capsule 300 µg
- ONBREZ BREEZHALER inhalation powder, hard capsule 150 µg
- ONBREZ BREEZHALER inhalation powder, hard capsule 300 µg
- OSLIF BREEZHALER inhalation powder, hard capsule 150 µg
- OSLIF BREEZHALER inhalation powder, hard capsule 300 µg
- SEEBRI BREEZHALER inhalation powder, hard capsule 44 µg
- TOVANOR BREEZHALER inhalation powder 44 µg
- ULTIBRO BREEZHALER inhalation powder, hard capsule 85 µg+43 µg
- ULUNAR BREEZHALER inhalation powder, hard capsule 85 µg+43 µg
- XOLAIR powder and solvent for solution for injection 150 mg+2 ml
- XOLAIR powder and solvent for solution for injection 75 mg+2 ml
- XOLAIR PREFILLED SYRINGE solution for injection
- XOTERNA BREEZHALER inhalation powder, hard capsule 85 µg+43 µg
- ZIMBUS BREEZHALER inhalation powder, hard capsule 114 µg+46 µg+136 µg
- S01 - Oftalmológicos
- AZARGA eye drops, suspension 0.5%+1%
- AZOPT eye drops, suspension 1%
- BEOVU PREFILLED SYRINGE solution for injection 120 mg/ ml
- DUOTRAV eye drops, solution 0.5%+0.004%
- IZBA eye drops, solution 30 µg/ml
- LUCENTIS solution for injection 10 mg/ml
- OPATANOL eye drops, solution 0.1%
- SIMBRINZA eye drops, suspension 10 mg/ml+2 mg/ml
- TRAVATAN eye drops, solution 0.004%
- V03 - Todos los demás preparados terapéuticos
- EXJADE DISPERSIBLE dispersible tablet 125 mg - 250 mg - 50 mg
- EXJADE film-coated tablet 180 mg
- EXJADE film-coated tablet 360 mg
- EXJADE film-coated tablet 90 mg
- EXJADE granules 180 mg
- EXJADE granules 360 mg
- EXJADE granules 90 mg